Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris caught up with Proactive London's Andrew Scott after news they've hired one of Pfizer’s top executives to become its first chief operating officer.
Investor deep dive
Circassia on track to achieve underlying profitability in 2020 after recent US approvals
Full interview: Circassia hires Pfizer exec as it continues transition to commerical business
Quick facts: Circassia Pharmaceuticals
Market Cap: £67.92 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Circassia Pharmaceuticals named herein, including the promotion by the Company of Circassia Pharmaceuticals in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE